Are There Any Emerging Therapies Targeting Nucleotide Synthesis?
Recent advances in cancer research have led to the development of novel therapies targeting nucleotide synthesis. These include small molecule inhibitors that are more selective for cancer-specific enzymes and pathways. Immunotherapies and gene editing technologies are also being explored to disrupt nucleotide synthesis in cancer cells specifically. The integration of these approaches with traditional chemotherapy could enhance treatment efficacy and reduce side effects.
